4
Changes in Ownership
Can-Fite BioPharma Ltd. Filed Acc 0001213900-26-066290
Options or other derivatives
- CEO, CFO and COO acquired 24,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Farbstein Motti · CEO, CFO and COO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-04 | Grant or award : show line 1 in the form Options to Purchase Ordinary Shares | +24,000 | 33,132 | D |
Loading xslF345X06/ownership.xml…